Fund Name | Location |
Accordance Ventures LP. | - |
Crest Communications Holdings | Archer, Florida, United States |
Digital Health Ventures | Berlin, Berlin, Germany |
Entropic | California, San Diego, United States |
Googol Technology | China, Hong Kong, Kowloon |
Graham Holdings | Arlington, United States, Virginia |
Hambrecht EU Capital | - |
Hear Music | Beverly Hills, California, United States |
Leye Holding | Beijing, Beijing, China |
MEMG Family Office. | - |
Normandy Ventures | New Jersey, Skillman, United States |
Petra Group | Australia, Melbourne, Victoria |
Qirui Youkang | China, Jiangsu, Nanjing |
Riverside Company | New York, New York, United States |
Rubicon Technology Partners | California, Menlo Park, United States |
TeraVault Ventures | British Columbia, Canada, Vancouver |
Wand Partners | New York, New York, United States |
Y Combinator Continuity Fund | California, Mountain View, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
AFFiNE | 14 Feb 2023 | - | |||
Boyue Bio | $23M | 09 May 2022 | Hangzhou, Zhejiang, China | ||
Hesguard | $15M | 26 Dec 2021 | Suzhou, Jiangsu, China | ||
Innogen Pharmaceutical | $120M | 23 Dec 2021 | Shanghai, Shanghai, China | ||
Gongye Technology | 20 Oct 2021 | Dongguang, Guangdong, China | |||
Oatoat | $2M | 29 Mar 2021 | Dongcheng District, Beijing, China | ||
Singleron Biotechnologies | $30M | 06 Sep 2020 | Xuanwu District, Jiangsu, China | ||
Bichen Pharmaceutical | $20M | 07 Aug 2020 | Shanghai, Shanghai, China | ||
ORIGITECH | 22 Jan 2020 | Shanghai, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
AFFiNE | 14 Feb 2023 | - | |||
Boyue Bio | $23M | 09 May 2022 | Hangzhou, Zhejiang, China | ||
Hesguard | $15M | 26 Dec 2021 | Suzhou, Jiangsu, China | ||
Innogen Pharmaceutical | $120M | 23 Dec 2021 | Shanghai, Shanghai, China | ||
Gongye Technology | 20 Oct 2021 | Dongguang, Guangdong, China | |||
Oatoat | $2M | 29 Mar 2021 | Dongcheng District, Beijing, China | ||
Singleron Biotechnologies | $30M | 06 Sep 2020 | Xuanwu District, Jiangsu, China | ||
Bichen Pharmaceutical | $20M | 07 Aug 2020 | Shanghai, Shanghai, China | ||
ORIGITECH | 22 Jan 2020 | Shanghai, China |